# Editorial: Novel theranostic agents for precision therapeutics

**Authors:** Shahid Karim, Nasir Ali Siddiqui, Mohammad Imran Khan, Muhammad Wahajuddin, Shariq Syed

PMC · DOI: 10.3389/fphar.2024.1407366 · 2024-04-17

## Full-text entities

- **Genes:** AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, FOLH1 (folate hydrolase 1) [NCBI Gene 2346] {aka FGCP, FOLH, GCP2, GCPII, NAALAD1, PSM}, PIK3CG (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma) [NCBI Gene 5294] {aka IMD97, PI3CG, PI3K, PI3Kgamma, PIK3, p110gamma}, CYP19A1 (cytochrome P450 family 19 subfamily A member 1) [NCBI Gene 1588] {aka ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}
- **Diseases:** MCF-7 cancer (MESH:C565201), prostate cancer (MESH:D011471), Ovarian cancer (MESH:D010051), acute renal damage (MESH:D058186), breast cancer (MESH:D001943), cancer (MESH:D009369)
- **Chemicals:** GCG (MESH:D005934), EGCG (MESH:C045651), flavonoids (MESH:D005419), mangiferin (MESH:C013592), ATP (MESH:D000255), Gallated catechins (-), gentamicin (MESH:D005839), catechin (MESH:D002392), curcumin (MESH:D003474), neo-tanshinlactone (MESH:C494351), 68Ga (MESH:C000615430), chalcone (MESH:D002599), Gymnemic acid (MESH:C007898)
- **Species:** Homo sapiens (human, species) [taxon 9606], Gymnema sylvestre (species) [taxon 4068]
- **Mutations:** L858R

---
Source: https://tomesphere.com/paper/PMC11061521